Table 2. Severity and clinical management of asthma population prescribed SABA alone, by number of SABA inhalers (N=8,227).
| Total N (%) | 1–3 N (%) | 4–12 N (%) | 13+N (%) | |
|---|---|---|---|---|
| 8,227 (100.0) | 5,888 (71.6) | 2,054 (25.0) | 285 (3.5) | |
|
Clinical measures | ||||
| Asthma review | 7,176 (87.2) | 4,963 (84.3) | 1,936 (94.3) | 277 (97.2) |
| Asthma management plan | 5,875 (71.4) | 3,977 (67.5) | 1,653 (80.5) | 245 (86.0) |
| Asthma step recorded | 6,077 (73.9) | 4,076 (69.2) | 1,740 (84.7) | 261 (91.6) |
|
Asthma severitya | ||||
| Step 1 | 4,106 (67.6) | 2,901 (71.2) | 1,076 (61.8) | 129 (49.4) |
| Step 2 | 1,683 (27.7) | 1,039 (25.5) | 543 (31.2) | 101 (38.7) |
| Step 3 | 270 (4.4) | 133 (3.3) | 111 (6.4) | 26 (10.0) |
| Step 4/5 | 18 (0.3) | 3 (0.1) | 10 (0.6) | 5 (1.9) |
|
Healthcare resource use | ||||
| Count IP episodes | 55 | 20 | 33 | 2 |
| Crude IP episode, rate per 100 population | 0.67 | 0.34 | 1.61 | 0.70 |
Abbreviations: IP, inpatient; SABA, short-acting β2-agonist.
a
Asthma step % as a proportion of total with asthma step recorded.